nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—SLC22A1—hematologic cancer	0.169	0.775	CbGaD
Quinine—ABCB1—hematologic cancer	0.0493	0.225	CbGaD
Quinine—SLCO1A2—Chlorambucil—hematologic cancer	0.0183	0.0365	CbGbCtD
Quinine—SLC22A2—Daunorubicin—hematologic cancer	0.0131	0.0262	CbGbCtD
Quinine—SLC22A2—Cytarabine—hematologic cancer	0.0116	0.0231	CbGbCtD
Quinine—SLC22A2—Cladribine—hematologic cancer	0.0109	0.0218	CbGbCtD
Quinine—SLC22A1—Cytarabine—hematologic cancer	0.0101	0.0201	CbGbCtD
Quinine—SLC22A2—Imatinib—hematologic cancer	0.0101	0.0201	CbGbCtD
Quinine—CYP1A2—Anagrelide—hematologic cancer	0.00984	0.0196	CbGbCtD
Quinine—CYP1A1—Methoxsalen—hematologic cancer	0.00984	0.0196	CbGbCtD
Quinine—SLC22A1—Cladribine—hematologic cancer	0.00951	0.019	CbGbCtD
Quinine—CYP1A1—Bortezomib—hematologic cancer	0.00936	0.0187	CbGbCtD
Quinine—CYP1A1—Daunorubicin—hematologic cancer	0.00895	0.0179	CbGbCtD
Quinine—SLC22A1—Imatinib—hematologic cancer	0.00874	0.0174	CbGbCtD
Quinine—CYP1A1—Thalidomide—hematologic cancer	0.00815	0.0163	CbGbCtD
Quinine—CYP1A1—Dacarbazine—hematologic cancer	0.00701	0.014	CbGbCtD
Quinine—SLCO1A2—Prednisolone—hematologic cancer	0.00691	0.0138	CbGbCtD
Quinine—SLCO1A2—Prednisone—hematologic cancer	0.00653	0.013	CbGbCtD
Quinine—CYP2E1—Thalidomide—hematologic cancer	0.0063	0.0126	CbGbCtD
Quinine—CYP2C9—Bexarotene—hematologic cancer	0.00615	0.0123	CbGbCtD
Quinine—ABCB1—Lenalidomide—hematologic cancer	0.00596	0.0119	CbGbCtD
Quinine—CYP3A7—Ifosfamide—hematologic cancer	0.00574	0.0115	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00574	0.0115	CbGbCtD
Quinine—SLC22A2—Vinblastine—hematologic cancer	0.00559	0.0111	CbGbCtD
Quinine—CYP1A1—Dasatinib—hematologic cancer	0.00551	0.011	CbGbCtD
Quinine—CYP3A7—Imatinib—hematologic cancer	0.00549	0.0109	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00549	0.0109	CbGbCtD
Quinine—CYP2E1—Dacarbazine—hematologic cancer	0.00542	0.0108	CbGbCtD
Quinine—CYP2C8—Bortezomib—hematologic cancer	0.0054	0.0108	CbGbCtD
Quinine—CYP3A5—Daunorubicin—hematologic cancer	0.00537	0.0107	CbGbCtD
Quinine—CYP2D6—Lomustine—hematologic cancer	0.00522	0.0104	CbGbCtD
Quinine—CYP1A2—Carmustine—hematologic cancer	0.00517	0.0103	CbGbCtD
Quinine—SLC22A2—Cisplatin—hematologic cancer	0.00512	0.0102	CbGbCtD
Quinine—CYP2C9—Idarubicin—hematologic cancer	0.00509	0.0102	CbGbCtD
Quinine—GP9—hematopoietic system—hematologic cancer	0.00492	0.155	CbGeAlD
Quinine—CYP3A5—Thalidomide—hematologic cancer	0.00489	0.00976	CbGbCtD
Quinine—CYP3A5—Teniposide—hematologic cancer	0.00467	0.00931	CbGbCtD
Quinine—CYP2D6—Idarubicin—hematologic cancer	0.00466	0.00929	CbGbCtD
Quinine—CYP2C19—Bortezomib—hematologic cancer	0.00453	0.00904	CbGbCtD
Quinine—CYP1A2—Methoxsalen—hematologic cancer	0.0044	0.00877	CbGbCtD
Quinine—CYP3A5—Ifosfamide—hematologic cancer	0.00431	0.0086	CbGbCtD
Quinine—CYP2E1—Mitoxantrone—hematologic cancer	0.0042	0.00838	CbGbCtD
Quinine—CYP1A2—Bortezomib—hematologic cancer	0.00418	0.00834	CbGbCtD
Quinine—CYP2C8—Ifosfamide—hematologic cancer	0.00414	0.00826	CbGbCtD
Quinine—CYP3A5—Imatinib—hematologic cancer	0.00412	0.00821	CbGbCtD
Quinine—SLCO1A2—Dexamethasone—hematologic cancer	0.00408	0.00813	CbGbCtD
Quinine—CYP1A2—Daunorubicin—hematologic cancer	0.004	0.00798	CbGbCtD
Quinine—CYP2D6—Hydroxyurea—hematologic cancer	0.00396	0.0079	CbGbCtD
Quinine—CYP2C19—Thalidomide—hematologic cancer	0.00395	0.00788	CbGbCtD
Quinine—CYP1A2—Alitretinoin—hematologic cancer	0.00392	0.00782	CbGbCtD
Quinine—CYP2C9—Bortezomib—hematologic cancer	0.00377	0.00752	CbGbCtD
Quinine—CYP2C19—Teniposide—hematologic cancer	0.00377	0.00751	CbGbCtD
Quinine—CYP1A2—Thalidomide—hematologic cancer	0.00364	0.00727	CbGbCtD
Quinine—CYP2C8—Nilotinib—hematologic cancer	0.0036	0.00717	CbGbCtD
Quinine—CYP3A4—Bexarotene—hematologic cancer	0.00357	0.00713	CbGbCtD
Quinine—ABCB1—Daunorubicin—hematologic cancer	0.0035	0.00698	CbGbCtD
Quinine—CYP2C19—Ifosfamide—hematologic cancer	0.00348	0.00693	CbGbCtD
Quinine—CYP2D6—Bortezomib—hematologic cancer	0.00344	0.00687	CbGbCtD
Quinine—CYP3A7—Irinotecan—hematologic cancer	0.00343	0.00684	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00343	0.00684	CbGbCtD
Quinine—ABCB1—Alitretinoin—hematologic cancer	0.00343	0.00683	CbGbCtD
Quinine—CYP3A4—Busulfan—hematologic cancer	0.00332	0.00663	CbGbCtD
Quinine—CYP3A4—Lomustine—hematologic cancer	0.00332	0.00663	CbGbCtD
Quinine—CYP2C19—Imatinib—hematologic cancer	0.00332	0.00662	CbGbCtD
Quinine—CYP3A5—Dasatinib—hematologic cancer	0.00331	0.00659	CbGbCtD
Quinine—CYP2C9—Thalidomide—hematologic cancer	0.00328	0.00655	CbGbCtD
Quinine—SLCO1A2—Methotrexate—hematologic cancer	0.00328	0.00654	CbGbCtD
Quinine—GP9—blood—hematologic cancer	0.00326	0.103	CbGeAlD
Quinine—CYP1A2—Dacarbazine—hematologic cancer	0.00313	0.00625	CbGbCtD
Quinine—CYP2C9—Teniposide—hematologic cancer	0.00313	0.00625	CbGbCtD
Quinine—CYP1A2—Imatinib—hematologic cancer	0.00306	0.00611	CbGbCtD
Quinine—CYP3A7—Vincristine—hematologic cancer	0.003	0.00598	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.003	0.00598	CbGbCtD
Quinine—CYP3A4—Thiotepa—hematologic cancer	0.00296	0.00591	CbGbCtD
Quinine—CYP2C9—Ifosfamide—hematologic cancer	0.00289	0.00576	CbGbCtD
Quinine—CYP1A1—Dexamethasone—hematologic cancer	0.00282	0.00563	CbGbCtD
Quinine—CYP2C9—Imatinib—hematologic cancer	0.00276	0.00551	CbGbCtD
Quinine—GP9—testis—hematologic cancer	0.00269	0.0849	CbGeAlD
Quinine—ABCB1—Imatinib—hematologic cancer	0.00268	0.00534	CbGbCtD
Quinine—CYP2E1—Etoposide—hematologic cancer	0.00265	0.00529	CbGbCtD
Quinine—CYP3A5—Irinotecan—hematologic cancer	0.00257	0.00513	CbGbCtD
Quinine—CYP2D6—Imatinib—hematologic cancer	0.00252	0.00504	CbGbCtD
Quinine—CYP2C9—Nilotinib—hematologic cancer	0.00251	0.005	CbGbCtD
Quinine—CYP1A2—Dasatinib—hematologic cancer	0.00246	0.00491	CbGbCtD
Quinine—ABCB1—Nilotinib—hematologic cancer	0.00243	0.00486	CbGbCtD
Quinine—ABCB1—Vinorelbine—hematologic cancer	0.00241	0.00482	CbGbCtD
Quinine—CYP3A4—Methoxsalen—hematologic cancer	0.0023	0.00459	CbGbCtD
Quinine—CYP2D6—Nilotinib—hematologic cancer	0.00229	0.00458	CbGbCtD
Quinine—CYP2D6—Vinorelbine—hematologic cancer	0.00227	0.00454	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00226	0.0045	CbGbCtD
Quinine—CYP3A7—Dexamethasone—hematologic cancer	0.00226	0.0045	CbGbCtD
Quinine—CYP3A5—Vincristine—hematologic cancer	0.00225	0.00448	CbGbCtD
Quinine—CYP3A4—Bortezomib—hematologic cancer	0.00219	0.00437	CbGbCtD
Quinine—CYP2C19—Prednisone—hematologic cancer	0.00219	0.00436	CbGbCtD
Quinine—CYP2E1—Dexamethasone—hematologic cancer	0.00218	0.00435	CbGbCtD
Quinine—ABCB1—Dasatinib—hematologic cancer	0.00215	0.00429	CbGbCtD
Quinine—ABCB1—Mitoxantrone—hematologic cancer	0.00212	0.00424	CbGbCtD
Quinine—CYP3A4—Daunorubicin—hematologic cancer	0.0021	0.00418	CbGbCtD
Quinine—CYP3A5—Etoposide—hematologic cancer	0.00206	0.00411	CbGbCtD
Quinine—CYP2C8—Etoposide—hematologic cancer	0.00198	0.00395	CbGbCtD
Quinine—ABCB1—Betamethasone—hematologic cancer	0.00189	0.00378	CbGbCtD
Quinine—ABCB1—Gemcitabine—hematologic cancer	0.00188	0.00374	CbGbCtD
Quinine—ABCB1—Prednisolone—hematologic cancer	0.00187	0.00373	CbGbCtD
Quinine—CYP3A4—Cytarabine—hematologic cancer	0.00185	0.00369	CbGbCtD
Quinine—CYP3A4—Teniposide—hematologic cancer	0.00182	0.00363	CbGbCtD
Quinine—ABCB1—Prednisone—hematologic cancer	0.00176	0.00352	CbGbCtD
Quinine—CYP3A5—Dexamethasone—hematologic cancer	0.00169	0.00338	CbGbCtD
Quinine—CYP3A4—Ifosfamide—hematologic cancer	0.00168	0.00335	CbGbCtD
Quinine—ABCB1—Irinotecan—hematologic cancer	0.00167	0.00334	CbGbCtD
Quinine—CYP2C8—Dexamethasone—hematologic cancer	0.00163	0.00325	CbGbCtD
Quinine—CYP3A4—Imatinib—hematologic cancer	0.0016	0.0032	CbGbCtD
Quinine—CYP1A2—Etoposide—hematologic cancer	0.00153	0.00306	CbGbCtD
Quinine—CYP3A4—Ruxolitinib—hematologic cancer	0.00151	0.00301	CbGbCtD
Quinine—ABCB1—Vinblastine—hematologic cancer	0.00149	0.00297	CbGbCtD
Quinine—ABCB1—Vincristine—hematologic cancer	0.00146	0.00292	CbGbCtD
Quinine—CYP3A4—Nilotinib—hematologic cancer	0.00146	0.00291	CbGbCtD
Quinine—CYP3A4—Vinorelbine—hematologic cancer	0.00145	0.00289	CbGbCtD
Quinine—CYP2C9—Cisplatin—hematologic cancer	0.00141	0.0028	CbGbCtD
Quinine—CYP2D6—Vinblastine—hematologic cancer	0.0014	0.0028	CbGbCtD
Quinine—CYP2C19—Dexamethasone—hematologic cancer	0.00137	0.00272	CbGbCtD
Quinine—ABCB1—Cisplatin—hematologic cancer	0.00136	0.00272	CbGbCtD
Quinine—KCNN4—hematopoietic system—hematologic cancer	0.00134	0.0423	CbGeAlD
Quinine—ABCB1—Etoposide—hematologic cancer	0.00134	0.00267	CbGbCtD
Quinine—CYP3A4—Triamcinolone—hematologic cancer	0.00132	0.00264	CbGbCtD
Quinine—CYP3A4—Dasatinib—hematologic cancer	0.00129	0.00257	CbGbCtD
Quinine—CYP3A4—Mitoxantrone—hematologic cancer	0.00127	0.00254	CbGbCtD
Quinine—CYP2C9—Dexamethasone—hematologic cancer	0.00114	0.00226	CbGbCtD
Quinine—CYP3A4—Betamethasone—hematologic cancer	0.00113	0.00226	CbGbCtD
Quinine—CYP3A4—Prednisolone—hematologic cancer	0.00112	0.00223	CbGbCtD
Quinine—ABCB1—Dexamethasone—hematologic cancer	0.0011	0.0022	CbGbCtD
Quinine—CYP3A4—Prednisone—hematologic cancer	0.00106	0.00211	CbGbCtD
Quinine—CYP2D6—Dexamethasone—hematologic cancer	0.00104	0.00207	CbGbCtD
Quinine—CYP3A4—Irinotecan—hematologic cancer	0.001	0.002	CbGbCtD
Quinine—ABCB1—Doxorubicin—hematologic cancer	0.000914	0.00182	CbGbCtD
Quinine—CYP3A4—Vinblastine—hematologic cancer	0.000891	0.00178	CbGbCtD
Quinine—KCNN4—blood—hematologic cancer	0.000889	0.028	CbGeAlD
Quinine—ABCB1—Methotrexate—hematologic cancer	0.000885	0.00177	CbGbCtD
Quinine—CYP3A4—Vincristine—hematologic cancer	0.000876	0.00175	CbGbCtD
Quinine—CYP2D6—Doxorubicin—hematologic cancer	0.000861	0.00172	CbGbCtD
Quinine—KCNN4—bone marrow—hematologic cancer	0.00086	0.0271	CbGeAlD
Quinine—CYP3A4—Etoposide—hematologic cancer	0.000803	0.0016	CbGbCtD
Quinine—KCNN4—lung—hematologic cancer	0.000779	0.0245	CbGeAlD
Quinine—KCNN4—testis—hematologic cancer	0.000735	0.0232	CbGeAlD
Quinine—SLCO1A2—hematopoietic system—hematologic cancer	0.000689	0.0217	CbGeAlD
Quinine—CYP3A4—Dexamethasone—hematologic cancer	0.00066	0.00132	CbGbCtD
Quinine—Quinidine—SLC22A1—hematologic cancer	0.000649	0.775	CrCbGaD
Quinine—CYP2C19—hematopoietic system—hematologic cancer	0.000551	0.0174	CbGeAlD
Quinine—CYP3A4—Doxorubicin—hematologic cancer	0.000548	0.00109	CbGbCtD
Quinine—KCNN4—lymph node—hematologic cancer	0.000533	0.0168	CbGeAlD
Quinine—KCNH2—hematopoietic system—hematologic cancer	0.000526	0.0166	CbGeAlD
Quinine—SLC22A4—blood—hematologic cancer	0.000498	0.0157	CbGeAlD
Quinine—SLC22A4—bone marrow—hematologic cancer	0.000481	0.0152	CbGeAlD
Quinine—CYP2C8—hematopoietic system—hematologic cancer	0.000481	0.0152	CbGeAlD
Quinine—SLC22A1—blood—hematologic cancer	0.000474	0.0149	CbGeAlD
Quinine—CYP1A2—hematopoietic system—hematologic cancer	0.00045	0.0142	CbGeAlD
Quinine—CYP1A1—hematopoietic system—hematologic cancer	0.000444	0.014	CbGeAlD
Quinine—SLC22A4—lung—hematologic cancer	0.000436	0.0137	CbGeAlD
Quinine—CYP3A5—hematopoietic system—hematologic cancer	0.000434	0.0137	CbGeAlD
Quinine—CYP2C9—hematopoietic system—hematologic cancer	0.000427	0.0135	CbGeAlD
Quinine—CYP2E1—hematopoietic system—hematologic cancer	0.000405	0.0128	CbGeAlD
Quinine—SLCO1A2—lung—hematologic cancer	0.0004	0.0126	CbGeAlD
Quinine—SLCO1A2—testis—hematologic cancer	0.000377	0.0119	CbGeAlD
Quinine—CYP2C19—blood—hematologic cancer	0.000365	0.0115	CbGeAlD
Quinine—KCNH2—blood—hematologic cancer	0.000348	0.011	CbGeAlD
Quinine—KCNH2—bone marrow—hematologic cancer	0.000337	0.0106	CbGeAlD
Quinine—SLC22A5—blood—hematologic cancer	0.000329	0.0104	CbGeAlD
Quinine—CYP3A4—hematopoietic system—hematologic cancer	0.000326	0.0103	CbGeAlD
Quinine—CYP2D6—hematopoietic system—hematologic cancer	0.000321	0.0101	CbGeAlD
Quinine—CYP2C8—blood—hematologic cancer	0.000319	0.01	CbGeAlD
Quinine—SLC22A4—lymph node—hematologic cancer	0.000298	0.0094	CbGeAlD
Quinine—CYP1A2—blood—hematologic cancer	0.000298	0.0094	CbGeAlD
Quinine—CYP1A1—blood—hematologic cancer	0.000294	0.00927	CbGeAlD
Quinine—SLC22A5—lung—hematologic cancer	0.000289	0.00909	CbGeAlD
Quinine—KCNH2—testis—hematologic cancer	0.000288	0.00908	CbGeAlD
Quinine—CYP3A5—blood—hematologic cancer	0.000288	0.00906	CbGeAlD
Quinine—CYP2C9—blood—hematologic cancer	0.000283	0.00892	CbGeAlD
Quinine—SLC22A5—testis—hematologic cancer	0.000272	0.00858	CbGeAlD
Quinine—CYP2E1—blood—hematologic cancer	0.000268	0.00845	CbGeAlD
Quinine—CYP2C8—testis—hematologic cancer	0.000264	0.00831	CbGeAlD
Quinine—CYP1A2—lung—hematologic cancer	0.000261	0.00824	CbGeAlD
Quinine—CYP1A1—lung—hematologic cancer	0.000258	0.00813	CbGeAlD
Quinine—CYP3A5—lung—hematologic cancer	0.000252	0.00794	CbGeAlD
Quinine—CYP2E1—lung—hematologic cancer	0.000235	0.00741	CbGeAlD
Quinine—ABCB1—hematopoietic system—hematologic cancer	0.000231	0.00727	CbGeAlD
Quinine—CYP2E1—testis—hematologic cancer	0.000222	0.00699	CbGeAlD
Quinine—CYP3A4—blood—hematologic cancer	0.000216	0.0068	CbGeAlD
Quinine—CYP2D6—blood—hematologic cancer	0.000212	0.00669	CbGeAlD
Quinine—KCNH2—lymph node—hematologic cancer	0.000209	0.00658	CbGeAlD
Quinine—SLC22A5—lymph node—hematologic cancer	0.000197	0.00622	CbGeAlD
Quinine—Quinidine—ABCB1—hematologic cancer	0.000189	0.225	CrCbGaD
Quinine—CYP1A1—lymph node—hematologic cancer	0.000176	0.00556	CbGeAlD
Quinine—CYP2D6—testis—hematologic cancer	0.000176	0.00554	CbGeAlD
Quinine—ABCB1—gonad—hematologic cancer	0.000175	0.00553	CbGeAlD
Quinine—ABCB1—blood—hematologic cancer	0.000153	0.00481	CbGeAlD
Quinine—ABCB1—bone marrow—hematologic cancer	0.000148	0.00466	CbGeAlD
Quinine—ABCB1—lung—hematologic cancer	0.000134	0.00422	CbGeAlD
Quinine—ABCB1—testis—hematologic cancer	0.000126	0.00398	CbGeAlD
Quinine—ABCB1—lymph node—hematologic cancer	9.16e-05	0.00289	CbGeAlD
Quinine—Chills—Methotrexate—hematologic cancer	1.96e-05	0.000118	CcSEcCtD
Quinine—Headache—Mitoxantrone—hematologic cancer	1.95e-05	0.000117	CcSEcCtD
Quinine—Headache—Irinotecan—hematologic cancer	1.95e-05	0.000117	CcSEcCtD
Quinine—Nausea—Ifosfamide—hematologic cancer	1.94e-05	0.000117	CcSEcCtD
Quinine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.94e-05	0.000116	CcSEcCtD
Quinine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.94e-05	0.000116	CcSEcCtD
Quinine—Myalgia—Prednisone—hematologic cancer	1.93e-05	0.000116	CcSEcCtD
Quinine—Feeling abnormal—Triamcinolone—hematologic cancer	1.93e-05	0.000116	CcSEcCtD
Quinine—Diarrhoea—Cisplatin—hematologic cancer	1.93e-05	0.000116	CcSEcCtD
Quinine—Erythema multiforme—Epirubicin—hematologic cancer	1.93e-05	0.000116	CcSEcCtD
Quinine—Vomiting—Gemcitabine—hematologic cancer	1.93e-05	0.000116	CcSEcCtD
Quinine—Bradycardia—Doxorubicin—hematologic cancer	1.92e-05	0.000115	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.92e-05	0.000115	CcSEcCtD
Quinine—Mental disorder—Methotrexate—hematologic cancer	1.91e-05	0.000115	CcSEcCtD
Quinine—Rash—Gemcitabine—hematologic cancer	1.91e-05	0.000115	CcSEcCtD
Quinine—Dermatitis—Gemcitabine—hematologic cancer	1.91e-05	0.000115	CcSEcCtD
Quinine—Eye disorder—Epirubicin—hematologic cancer	1.91e-05	0.000115	CcSEcCtD
Quinine—Hypersensitivity—Etoposide—hematologic cancer	1.91e-05	0.000114	CcSEcCtD
Quinine—Tinnitus—Epirubicin—hematologic cancer	1.9e-05	0.000114	CcSEcCtD
Quinine—Erythema—Methotrexate—hematologic cancer	1.9e-05	0.000114	CcSEcCtD
Quinine—Malnutrition—Methotrexate—hematologic cancer	1.9e-05	0.000114	CcSEcCtD
Quinine—Haemoglobin—Doxorubicin—hematologic cancer	1.9e-05	0.000114	CcSEcCtD
Quinine—Headache—Gemcitabine—hematologic cancer	1.9e-05	0.000114	CcSEcCtD
Quinine—Nausea—Vincristine—hematologic cancer	1.9e-05	0.000114	CcSEcCtD
Quinine—Flushing—Epirubicin—hematologic cancer	1.89e-05	0.000114	CcSEcCtD
Quinine—Cardiac disorder—Epirubicin—hematologic cancer	1.89e-05	0.000114	CcSEcCtD
Quinine—Hepatitis—Doxorubicin—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Quinine—Haemorrhage—Doxorubicin—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Quinine—Hypersensitivity—Prednisolone—hematologic cancer	1.88e-05	0.000113	CcSEcCtD
Quinine—Urinary tract disorder—Doxorubicin—hematologic cancer	1.86e-05	0.000112	CcSEcCtD
Quinine—Urticaria—Triamcinolone—hematologic cancer	1.86e-05	0.000112	CcSEcCtD
Quinine—Asthenia—Etoposide—hematologic cancer	1.86e-05	0.000111	CcSEcCtD
Quinine—Body temperature increased—Triamcinolone—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Oedema—Prednisone—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Urethral disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Decreased appetite—Dexamethasone—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Decreased appetite—Betamethasone—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Nausea—Irinotecan—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Nausea—Mitoxantrone—hematologic cancer	1.85e-05	0.000111	CcSEcCtD
Quinine—Immune system disorder—Epirubicin—hematologic cancer	1.84e-05	0.000111	CcSEcCtD
Quinine—Mediastinal disorder—Epirubicin—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Quinine—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Quinine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.84e-05	0.00011	CcSEcCtD
Quinine—Chills—Epirubicin—hematologic cancer	1.83e-05	0.00011	CcSEcCtD
Quinine—Pruritus—Etoposide—hematologic cancer	1.83e-05	0.00011	CcSEcCtD
Quinine—Shock—Prednisone—hematologic cancer	1.82e-05	0.00011	CcSEcCtD
Quinine—Visual impairment—Doxorubicin—hematologic cancer	1.82e-05	0.000109	CcSEcCtD
Quinine—Nervous system disorder—Prednisone—hematologic cancer	1.82e-05	0.000109	CcSEcCtD
Quinine—Tachycardia—Prednisone—hematologic cancer	1.81e-05	0.000109	CcSEcCtD
Quinine—Skin disorder—Prednisone—hematologic cancer	1.8e-05	0.000108	CcSEcCtD
Quinine—Nausea—Gemcitabine—hematologic cancer	1.8e-05	0.000108	CcSEcCtD
Quinine—Vomiting—Cisplatin—hematologic cancer	1.79e-05	0.000108	CcSEcCtD
Quinine—Hyperhidrosis—Prednisone—hematologic cancer	1.79e-05	0.000108	CcSEcCtD
Quinine—Vision blurred—Methotrexate—hematologic cancer	1.79e-05	0.000107	CcSEcCtD
Quinine—Mental disorder—Epirubicin—hematologic cancer	1.79e-05	0.000107	CcSEcCtD
Quinine—Erythema multiforme—Doxorubicin—hematologic cancer	1.78e-05	0.000107	CcSEcCtD
Quinine—Rash—Cisplatin—hematologic cancer	1.78e-05	0.000107	CcSEcCtD
Quinine—Dermatitis—Cisplatin—hematologic cancer	1.78e-05	0.000107	CcSEcCtD
Quinine—Erythema—Epirubicin—hematologic cancer	1.78e-05	0.000107	CcSEcCtD
Quinine—Malnutrition—Epirubicin—hematologic cancer	1.78e-05	0.000107	CcSEcCtD
Quinine—Diarrhoea—Etoposide—hematologic cancer	1.77e-05	0.000106	CcSEcCtD
Quinine—Anorexia—Prednisone—hematologic cancer	1.77e-05	0.000106	CcSEcCtD
Quinine—Eye disorder—Doxorubicin—hematologic cancer	1.76e-05	0.000106	CcSEcCtD
Quinine—Tinnitus—Doxorubicin—hematologic cancer	1.76e-05	0.000106	CcSEcCtD
Quinine—Feeling abnormal—Betamethasone—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Quinine—Feeling abnormal—Dexamethasone—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Quinine—Flushing—Doxorubicin—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Quinine—Cardiac disorder—Doxorubicin—hematologic cancer	1.75e-05	0.000105	CcSEcCtD
Quinine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.74e-05	0.000105	CcSEcCtD
Quinine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.74e-05	0.000105	CcSEcCtD
Quinine—Hypersensitivity—Triamcinolone—hematologic cancer	1.73e-05	0.000104	CcSEcCtD
Quinine—Dizziness—Etoposide—hematologic cancer	1.71e-05	0.000103	CcSEcCtD
Quinine—Immune system disorder—Doxorubicin—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Quinine—Vertigo—Methotrexate—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Quinine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.7e-05	0.000102	CcSEcCtD
Quinine—Leukopenia—Methotrexate—hematologic cancer	1.7e-05	0.000102	CcSEcCtD
Quinine—Chills—Doxorubicin—hematologic cancer	1.69e-05	0.000102	CcSEcCtD
Quinine—Urticaria—Betamethasone—hematologic cancer	1.69e-05	0.000102	CcSEcCtD
Quinine—Urticaria—Dexamethasone—hematologic cancer	1.69e-05	0.000102	CcSEcCtD
Quinine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.69e-05	0.000101	CcSEcCtD
Quinine—Dizziness—Prednisolone—hematologic cancer	1.69e-05	0.000101	CcSEcCtD
Quinine—Asthenia—Triamcinolone—hematologic cancer	1.68e-05	0.000101	CcSEcCtD
Quinine—Body temperature increased—Dexamethasone—hematologic cancer	1.68e-05	0.000101	CcSEcCtD
Quinine—Body temperature increased—Betamethasone—hematologic cancer	1.68e-05	0.000101	CcSEcCtD
Quinine—Abdominal pain—Betamethasone—hematologic cancer	1.68e-05	0.000101	CcSEcCtD
Quinine—Abdominal pain—Dexamethasone—hematologic cancer	1.68e-05	0.000101	CcSEcCtD
Quinine—Nausea—Cisplatin—hematologic cancer	1.68e-05	0.000101	CcSEcCtD
Quinine—Vision blurred—Epirubicin—hematologic cancer	1.67e-05	0.000101	CcSEcCtD
Quinine—Pruritus—Triamcinolone—hematologic cancer	1.66e-05	9.97e-05	CcSEcCtD
Quinine—Mental disorder—Doxorubicin—hematologic cancer	1.65e-05	9.94e-05	CcSEcCtD
Quinine—Convulsion—Methotrexate—hematologic cancer	1.64e-05	9.88e-05	CcSEcCtD
Quinine—Vomiting—Etoposide—hematologic cancer	1.64e-05	9.88e-05	CcSEcCtD
Quinine—Malnutrition—Doxorubicin—hematologic cancer	1.64e-05	9.87e-05	CcSEcCtD
Quinine—Erythema—Doxorubicin—hematologic cancer	1.64e-05	9.87e-05	CcSEcCtD
Quinine—Agitation—Epirubicin—hematologic cancer	1.63e-05	9.81e-05	CcSEcCtD
Quinine—Rash—Etoposide—hematologic cancer	1.63e-05	9.8e-05	CcSEcCtD
Quinine—Dermatitis—Etoposide—hematologic cancer	1.63e-05	9.79e-05	CcSEcCtD
Quinine—Headache—Etoposide—hematologic cancer	1.62e-05	9.73e-05	CcSEcCtD
Quinine—Chest pain—Methotrexate—hematologic cancer	1.62e-05	9.71e-05	CcSEcCtD
Quinine—Myalgia—Methotrexate—hematologic cancer	1.62e-05	9.71e-05	CcSEcCtD
Quinine—Decreased appetite—Prednisone—hematologic cancer	1.61e-05	9.68e-05	CcSEcCtD
Quinine—Rash—Prednisolone—hematologic cancer	1.61e-05	9.66e-05	CcSEcCtD
Quinine—Dermatitis—Prednisolone—hematologic cancer	1.61e-05	9.65e-05	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.6e-05	9.64e-05	CcSEcCtD
Quinine—Headache—Prednisolone—hematologic cancer	1.6e-05	9.6e-05	CcSEcCtD
Quinine—Vertigo—Epirubicin—hematologic cancer	1.6e-05	9.59e-05	CcSEcCtD
Quinine—Syncope—Epirubicin—hematologic cancer	1.59e-05	9.57e-05	CcSEcCtD
Quinine—Leukopenia—Epirubicin—hematologic cancer	1.59e-05	9.55e-05	CcSEcCtD
Quinine—Palpitations—Epirubicin—hematologic cancer	1.57e-05	9.43e-05	CcSEcCtD
Quinine—Confusional state—Methotrexate—hematologic cancer	1.56e-05	9.38e-05	CcSEcCtD
Quinine—Loss of consciousness—Epirubicin—hematologic cancer	1.56e-05	9.38e-05	CcSEcCtD
Quinine—Dizziness—Triamcinolone—hematologic cancer	1.55e-05	9.32e-05	CcSEcCtD
Quinine—Vision blurred—Doxorubicin—hematologic cancer	1.55e-05	9.31e-05	CcSEcCtD
Quinine—Convulsion—Epirubicin—hematologic cancer	1.54e-05	9.25e-05	CcSEcCtD
Quinine—Nausea—Etoposide—hematologic cancer	1.54e-05	9.23e-05	CcSEcCtD
Quinine—Feeling abnormal—Prednisone—hematologic cancer	1.53e-05	9.18e-05	CcSEcCtD
Quinine—Asthenia—Dexamethasone—hematologic cancer	1.53e-05	9.17e-05	CcSEcCtD
Quinine—Asthenia—Betamethasone—hematologic cancer	1.53e-05	9.17e-05	CcSEcCtD
Quinine—Nervous system disorder—Methotrexate—hematologic cancer	1.52e-05	9.13e-05	CcSEcCtD
Quinine—Thrombocytopenia—Methotrexate—hematologic cancer	1.52e-05	9.11e-05	CcSEcCtD
Quinine—Gastrointestinal pain—Prednisone—hematologic cancer	1.52e-05	9.11e-05	CcSEcCtD
Quinine—Nausea—Prednisolone—hematologic cancer	1.51e-05	9.1e-05	CcSEcCtD
Quinine—Chest pain—Epirubicin—hematologic cancer	1.51e-05	9.08e-05	CcSEcCtD
Quinine—Myalgia—Epirubicin—hematologic cancer	1.51e-05	9.08e-05	CcSEcCtD
Quinine—Agitation—Doxorubicin—hematologic cancer	1.51e-05	9.07e-05	CcSEcCtD
Quinine—Pruritus—Dexamethasone—hematologic cancer	1.51e-05	9.05e-05	CcSEcCtD
Quinine—Pruritus—Betamethasone—hematologic cancer	1.51e-05	9.05e-05	CcSEcCtD
Quinine—Skin disorder—Methotrexate—hematologic cancer	1.5e-05	9.04e-05	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.5e-05	9.02e-05	CcSEcCtD
Quinine—Hyperhidrosis—Methotrexate—hematologic cancer	1.5e-05	9e-05	CcSEcCtD
Quinine—Vomiting—Triamcinolone—hematologic cancer	1.49e-05	8.96e-05	CcSEcCtD
Quinine—Rash—Triamcinolone—hematologic cancer	1.48e-05	8.89e-05	CcSEcCtD
Quinine—Dermatitis—Triamcinolone—hematologic cancer	1.48e-05	8.88e-05	CcSEcCtD
Quinine—Vertigo—Doxorubicin—hematologic cancer	1.48e-05	8.87e-05	CcSEcCtD
Quinine—Anorexia—Methotrexate—hematologic cancer	1.48e-05	8.87e-05	CcSEcCtD
Quinine—Syncope—Doxorubicin—hematologic cancer	1.47e-05	8.85e-05	CcSEcCtD
Quinine—Urticaria—Prednisone—hematologic cancer	1.47e-05	8.85e-05	CcSEcCtD
Quinine—Leukopenia—Doxorubicin—hematologic cancer	1.47e-05	8.84e-05	CcSEcCtD
Quinine—Headache—Triamcinolone—hematologic cancer	1.47e-05	8.83e-05	CcSEcCtD
Quinine—Abdominal pain—Prednisone—hematologic cancer	1.47e-05	8.8e-05	CcSEcCtD
Quinine—Body temperature increased—Prednisone—hematologic cancer	1.47e-05	8.8e-05	CcSEcCtD
Quinine—Confusional state—Epirubicin—hematologic cancer	1.46e-05	8.78e-05	CcSEcCtD
Quinine—Diarrhoea—Betamethasone—hematologic cancer	1.46e-05	8.75e-05	CcSEcCtD
Quinine—Diarrhoea—Dexamethasone—hematologic cancer	1.46e-05	8.75e-05	CcSEcCtD
Quinine—Palpitations—Doxorubicin—hematologic cancer	1.45e-05	8.73e-05	CcSEcCtD
Quinine—Oedema—Epirubicin—hematologic cancer	1.45e-05	8.71e-05	CcSEcCtD
Quinine—Hypotension—Methotrexate—hematologic cancer	1.45e-05	8.7e-05	CcSEcCtD
Quinine—Loss of consciousness—Doxorubicin—hematologic cancer	1.44e-05	8.68e-05	CcSEcCtD
Quinine—Shock—Epirubicin—hematologic cancer	1.43e-05	8.57e-05	CcSEcCtD
Quinine—Convulsion—Doxorubicin—hematologic cancer	1.42e-05	8.55e-05	CcSEcCtD
Quinine—Nervous system disorder—Epirubicin—hematologic cancer	1.42e-05	8.54e-05	CcSEcCtD
Quinine—Thrombocytopenia—Epirubicin—hematologic cancer	1.42e-05	8.53e-05	CcSEcCtD
Quinine—Tachycardia—Epirubicin—hematologic cancer	1.41e-05	8.5e-05	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.41e-05	8.48e-05	CcSEcCtD
Quinine—Skin disorder—Epirubicin—hematologic cancer	1.41e-05	8.46e-05	CcSEcCtD
Quinine—Dizziness—Dexamethasone—hematologic cancer	1.41e-05	8.46e-05	CcSEcCtD
Quinine—Dizziness—Betamethasone—hematologic cancer	1.41e-05	8.46e-05	CcSEcCtD
Quinine—Hyperhidrosis—Epirubicin—hematologic cancer	1.4e-05	8.42e-05	CcSEcCtD
Quinine—Chest pain—Doxorubicin—hematologic cancer	1.4e-05	8.41e-05	CcSEcCtD
Quinine—Myalgia—Doxorubicin—hematologic cancer	1.4e-05	8.41e-05	CcSEcCtD
Quinine—Nausea—Triamcinolone—hematologic cancer	1.39e-05	8.37e-05	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.39e-05	8.35e-05	CcSEcCtD
Quinine—Anorexia—Epirubicin—hematologic cancer	1.38e-05	8.3e-05	CcSEcCtD
Quinine—Dyspnoea—Methotrexate—hematologic cancer	1.38e-05	8.3e-05	CcSEcCtD
Quinine—Hypersensitivity—Prednisone—hematologic cancer	1.37e-05	8.2e-05	CcSEcCtD
Quinine—Hypotension—Epirubicin—hematologic cancer	1.35e-05	8.14e-05	CcSEcCtD
Quinine—Vomiting—Dexamethasone—hematologic cancer	1.35e-05	8.13e-05	CcSEcCtD
Quinine—Vomiting—Betamethasone—hematologic cancer	1.35e-05	8.13e-05	CcSEcCtD
Quinine—Confusional state—Doxorubicin—hematologic cancer	1.35e-05	8.13e-05	CcSEcCtD
Quinine—Decreased appetite—Methotrexate—hematologic cancer	1.35e-05	8.09e-05	CcSEcCtD
Quinine—Rash—Dexamethasone—hematologic cancer	1.34e-05	8.06e-05	CcSEcCtD
Quinine—Rash—Betamethasone—hematologic cancer	1.34e-05	8.06e-05	CcSEcCtD
Quinine—Oedema—Doxorubicin—hematologic cancer	1.34e-05	8.06e-05	CcSEcCtD
Quinine—Dermatitis—Dexamethasone—hematologic cancer	1.34e-05	8.05e-05	CcSEcCtD
Quinine—Dermatitis—Betamethasone—hematologic cancer	1.34e-05	8.05e-05	CcSEcCtD
Quinine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.34e-05	8.03e-05	CcSEcCtD
Quinine—Headache—Dexamethasone—hematologic cancer	1.33e-05	8.01e-05	CcSEcCtD
Quinine—Headache—Betamethasone—hematologic cancer	1.33e-05	8.01e-05	CcSEcCtD
Quinine—Asthenia—Prednisone—hematologic cancer	1.33e-05	7.99e-05	CcSEcCtD
Quinine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.32e-05	7.93e-05	CcSEcCtD
Quinine—Shock—Doxorubicin—hematologic cancer	1.32e-05	7.93e-05	CcSEcCtD
Quinine—Nervous system disorder—Doxorubicin—hematologic cancer	1.32e-05	7.9e-05	CcSEcCtD
Quinine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.31e-05	7.89e-05	CcSEcCtD
Quinine—Pruritus—Prednisone—hematologic cancer	1.31e-05	7.88e-05	CcSEcCtD
Quinine—Tachycardia—Doxorubicin—hematologic cancer	1.31e-05	7.86e-05	CcSEcCtD
Quinine—Skin disorder—Doxorubicin—hematologic cancer	1.3e-05	7.83e-05	CcSEcCtD
Quinine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.3e-05	7.79e-05	CcSEcCtD
Quinine—Dyspnoea—Epirubicin—hematologic cancer	1.29e-05	7.76e-05	CcSEcCtD
Quinine—Anorexia—Doxorubicin—hematologic cancer	1.28e-05	7.68e-05	CcSEcCtD
Quinine—Feeling abnormal—Methotrexate—hematologic cancer	1.28e-05	7.67e-05	CcSEcCtD
Quinine—Diarrhoea—Prednisone—hematologic cancer	1.27e-05	7.62e-05	CcSEcCtD
Quinine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.27e-05	7.61e-05	CcSEcCtD
Quinine—Nausea—Dexamethasone—hematologic cancer	1.26e-05	7.6e-05	CcSEcCtD
Quinine—Nausea—Betamethasone—hematologic cancer	1.26e-05	7.6e-05	CcSEcCtD
Quinine—Decreased appetite—Epirubicin—hematologic cancer	1.26e-05	7.57e-05	CcSEcCtD
Quinine—Hypotension—Doxorubicin—hematologic cancer	1.25e-05	7.53e-05	CcSEcCtD
Quinine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.25e-05	7.52e-05	CcSEcCtD
Quinine—Urticaria—Methotrexate—hematologic cancer	1.23e-05	7.39e-05	CcSEcCtD
Quinine—Dizziness—Prednisone—hematologic cancer	1.23e-05	7.36e-05	CcSEcCtD
Quinine—Abdominal pain—Methotrexate—hematologic cancer	1.22e-05	7.36e-05	CcSEcCtD
Quinine—Body temperature increased—Methotrexate—hematologic cancer	1.22e-05	7.36e-05	CcSEcCtD
Quinine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.22e-05	7.34e-05	CcSEcCtD
Quinine—Dyspnoea—Doxorubicin—hematologic cancer	1.2e-05	7.18e-05	CcSEcCtD
Quinine—Feeling abnormal—Epirubicin—hematologic cancer	1.19e-05	7.18e-05	CcSEcCtD
Quinine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.19e-05	7.12e-05	CcSEcCtD
Quinine—Vomiting—Prednisone—hematologic cancer	1.18e-05	7.08e-05	CcSEcCtD
Quinine—Rash—Prednisone—hematologic cancer	1.17e-05	7.02e-05	CcSEcCtD
Quinine—Dermatitis—Prednisone—hematologic cancer	1.17e-05	7.01e-05	CcSEcCtD
Quinine—Decreased appetite—Doxorubicin—hematologic cancer	1.17e-05	7.01e-05	CcSEcCtD
Quinine—Headache—Prednisone—hematologic cancer	1.16e-05	6.98e-05	CcSEcCtD
Quinine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.16e-05	6.96e-05	CcSEcCtD
Quinine—Urticaria—Epirubicin—hematologic cancer	1.15e-05	6.92e-05	CcSEcCtD
Quinine—Abdominal pain—Epirubicin—hematologic cancer	1.15e-05	6.88e-05	CcSEcCtD
Quinine—Body temperature increased—Epirubicin—hematologic cancer	1.15e-05	6.88e-05	CcSEcCtD
Quinine—Hypersensitivity—Methotrexate—hematologic cancer	1.14e-05	6.86e-05	CcSEcCtD
Quinine—Asthenia—Methotrexate—hematologic cancer	1.11e-05	6.68e-05	CcSEcCtD
Quinine—Feeling abnormal—Doxorubicin—hematologic cancer	1.11e-05	6.64e-05	CcSEcCtD
Quinine—Nausea—Prednisone—hematologic cancer	1.1e-05	6.61e-05	CcSEcCtD
Quinine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.1e-05	6.59e-05	CcSEcCtD
Quinine—Pruritus—Methotrexate—hematologic cancer	1.1e-05	6.58e-05	CcSEcCtD
Quinine—Hypersensitivity—Epirubicin—hematologic cancer	1.07e-05	6.42e-05	CcSEcCtD
Quinine—Urticaria—Doxorubicin—hematologic cancer	1.07e-05	6.4e-05	CcSEcCtD
Quinine—Abdominal pain—Doxorubicin—hematologic cancer	1.06e-05	6.37e-05	CcSEcCtD
Quinine—Body temperature increased—Doxorubicin—hematologic cancer	1.06e-05	6.37e-05	CcSEcCtD
Quinine—Diarrhoea—Methotrexate—hematologic cancer	1.06e-05	6.37e-05	CcSEcCtD
Quinine—Asthenia—Epirubicin—hematologic cancer	1.04e-05	6.25e-05	CcSEcCtD
Quinine—Pruritus—Epirubicin—hematologic cancer	1.03e-05	6.16e-05	CcSEcCtD
Quinine—Dizziness—Methotrexate—hematologic cancer	1.02e-05	6.15e-05	CcSEcCtD
Quinine—Diarrhoea—Epirubicin—hematologic cancer	9.92e-06	5.96e-05	CcSEcCtD
Quinine—Hypersensitivity—Doxorubicin—hematologic cancer	9.88e-06	5.94e-05	CcSEcCtD
Quinine—Vomiting—Methotrexate—hematologic cancer	9.85e-06	5.92e-05	CcSEcCtD
Quinine—Rash—Methotrexate—hematologic cancer	9.77e-06	5.87e-05	CcSEcCtD
Quinine—Dermatitis—Methotrexate—hematologic cancer	9.76e-06	5.86e-05	CcSEcCtD
Quinine—Headache—Methotrexate—hematologic cancer	9.7e-06	5.83e-05	CcSEcCtD
Quinine—Asthenia—Doxorubicin—hematologic cancer	9.62e-06	5.78e-05	CcSEcCtD
Quinine—Dizziness—Epirubicin—hematologic cancer	9.58e-06	5.76e-05	CcSEcCtD
Quinine—Pruritus—Doxorubicin—hematologic cancer	9.49e-06	5.7e-05	CcSEcCtD
Quinine—Vomiting—Epirubicin—hematologic cancer	9.22e-06	5.54e-05	CcSEcCtD
Quinine—Nausea—Methotrexate—hematologic cancer	9.2e-06	5.53e-05	CcSEcCtD
Quinine—Diarrhoea—Doxorubicin—hematologic cancer	9.18e-06	5.51e-05	CcSEcCtD
Quinine—Rash—Epirubicin—hematologic cancer	9.14e-06	5.49e-05	CcSEcCtD
Quinine—Dermatitis—Epirubicin—hematologic cancer	9.13e-06	5.49e-05	CcSEcCtD
Quinine—Headache—Epirubicin—hematologic cancer	9.08e-06	5.46e-05	CcSEcCtD
Quinine—Dizziness—Doxorubicin—hematologic cancer	8.87e-06	5.33e-05	CcSEcCtD
Quinine—Nausea—Epirubicin—hematologic cancer	8.61e-06	5.17e-05	CcSEcCtD
Quinine—Vomiting—Doxorubicin—hematologic cancer	8.53e-06	5.12e-05	CcSEcCtD
Quinine—Rash—Doxorubicin—hematologic cancer	8.46e-06	5.08e-05	CcSEcCtD
Quinine—Dermatitis—Doxorubicin—hematologic cancer	8.45e-06	5.08e-05	CcSEcCtD
Quinine—Headache—Doxorubicin—hematologic cancer	8.4e-06	5.05e-05	CcSEcCtD
Quinine—Nausea—Doxorubicin—hematologic cancer	7.97e-06	4.79e-05	CcSEcCtD
Quinine—CYP2C9—Metabolism—CYCS—hematologic cancer	1.81e-06	2.23e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.8e-06	2.22e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.79e-06	2.21e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.79e-06	2.21e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.77e-06	2.19e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	1.77e-06	2.18e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	1.77e-06	2.18e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.76e-06	2.17e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.75e-06	2.16e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	1.75e-06	2.15e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—MTHFR—hematologic cancer	1.74e-06	2.14e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.73e-06	2.14e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ALB—hematologic cancer	1.72e-06	2.13e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.72e-06	2.12e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—EP300—hematologic cancer	1.72e-06	2.12e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTP1—hematologic cancer	1.71e-06	2.1e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NUP98—hematologic cancer	1.69e-06	2.08e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.66e-06	2.04e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.66e-06	2.04e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	1.65e-06	2.03e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.64e-06	2.02e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.64e-06	2.02e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.64e-06	2.02e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	1.64e-06	2.02e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CD44—hematologic cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NQO1—hematologic cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NUP214—hematologic cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.62e-06	1.99e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.6e-06	1.97e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—MTR—hematologic cancer	1.6e-06	1.97e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.6e-06	1.97e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.59e-06	1.97e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.59e-06	1.96e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.59e-06	1.96e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.57e-06	1.93e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.57e-06	1.93e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—NCOR1—hematologic cancer	1.57e-06	1.93e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTM1—hematologic cancer	1.57e-06	1.93e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ENO2—hematologic cancer	1.56e-06	1.93e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYCS—hematologic cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.54e-06	1.9e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.54e-06	1.9e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.54e-06	1.89e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.51e-06	1.86e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SDC1—hematologic cancer	1.48e-06	1.83e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.48e-06	1.82e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.48e-06	1.82e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.47e-06	1.81e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CG—hematologic cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.46e-06	1.79e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.45e-06	1.78e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CREBBP—hematologic cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.42e-06	1.74e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTEN—hematologic cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTEN—hematologic cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—MTHFR—hematologic cancer	1.39e-06	1.71e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.36e-06	1.67e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—EP300—hematologic cancer	1.35e-06	1.66e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—EP300—hematologic cancer	1.35e-06	1.66e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.35e-06	1.66e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ALB—hematologic cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ALB—hematologic cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.32e-06	1.63e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTEN—hematologic cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.31e-06	1.61e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.31e-06	1.61e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.3e-06	1.6e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ALB—hematologic cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CD44—hematologic cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—EP300—hematologic cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	1.23e-06	1.51e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.21e-06	1.49e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ALB—hematologic cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.07e-06	1.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.07e-06	1.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ALB—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.02e-06	1.25e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ALB—hematologic cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	9.98e-07	1.23e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	9.96e-07	1.23e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.96e-07	1.23e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	9.91e-07	1.22e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	9.85e-07	1.21e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	9.82e-07	1.21e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—EP300—hematologic cancer	9.77e-07	1.2e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.75e-07	1.2e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—EP300—hematologic cancer	9.75e-07	1.2e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3R1—hematologic cancer	9.67e-07	1.19e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.67e-07	1.19e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.67e-07	1.19e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTEN—hematologic cancer	9.66e-07	1.19e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	9.65e-07	1.19e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EP300—hematologic cancer	9.6e-07	1.18e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	9.57e-07	1.18e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ALB—hematologic cancer	9.53e-07	1.17e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ALB—hematologic cancer	9.44e-07	1.16e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—SRC—hematologic cancer	9.34e-07	1.15e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	9.3e-07	1.15e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	9.28e-07	1.14e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—EP300—hematologic cancer	9.21e-07	1.13e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	9.15e-07	1.13e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	9.11e-07	1.12e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	9.09e-07	1.12e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	9.03e-07	1.11e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	9e-07	1.11e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	8.98e-07	1.11e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CB—hematologic cancer	8.93e-07	1.1e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTEN—hematologic cancer	8.85e-07	1.09e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CREBBP—hematologic cancer	8.62e-07	1.06e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	8.6e-07	1.06e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.54e-07	1.05e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—EP300—hematologic cancer	8.44e-07	1.04e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	8.41e-07	1.04e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—hematologic cancer	8.37e-07	1.03e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	8.35e-07	1.03e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	8.34e-07	1.03e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	8.18e-07	1.01e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—AKT1—hematologic cancer	8.15e-07	1e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—AKT1—hematologic cancer	8.14e-07	1e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ALB—hematologic cancer	8.07e-07	9.95e-06	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTEN—hematologic cancer	7.9e-07	9.74e-06	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	7.73e-07	9.53e-06	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.72e-07	9.51e-06	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTEN—hematologic cancer	7.71e-07	9.51e-06	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—AKT1—hematologic cancer	7.58e-07	9.35e-06	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—EP300—hematologic cancer	7.54e-07	9.29e-06	CbGpPWpGaD
Quinine—ABCB1—Metabolism—EP300—hematologic cancer	7.36e-07	9.07e-06	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTEN—hematologic cancer	7.27e-07	8.96e-06	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	7.23e-07	8.9e-06	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	7.21e-07	8.89e-06	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTEN—hematologic cancer	7.21e-07	8.88e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.18e-07	8.84e-06	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.13e-07	8.78e-06	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.1e-07	8.75e-06	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—EP300—hematologic cancer	6.93e-07	8.54e-06	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—EP300—hematologic cancer	6.87e-07	8.47e-06	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.87e-07	8.47e-06	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	6.81e-07	8.4e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.65e-07	8.2e-06	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	6.57e-07	8.1e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.31e-07	7.78e-06	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.29e-07	7.75e-06	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	6.25e-07	7.7e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALB—hematologic cancer	6.23e-07	7.68e-06	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTEN—hematologic cancer	6.16e-07	7.59e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.96e-07	7.34e-06	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—AKT1—hematologic cancer	5.9e-07	7.27e-06	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—AKT1—hematologic cancer	5.89e-07	7.26e-06	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—EP300—hematologic cancer	5.87e-07	7.24e-06	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.8e-07	7.15e-06	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	5.58e-07	6.87e-06	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—AKT1—hematologic cancer	5.57e-07	6.86e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.5e-07	6.78e-06	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.44e-07	6.71e-06	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	5.13e-07	6.32e-06	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—AKT1—hematologic cancer	5.1e-07	6.29e-06	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	5.08e-07	6.26e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.75e-07	5.86e-06	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—AKT1—hematologic cancer	4.55e-07	5.61e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—EP300—hematologic cancer	4.53e-07	5.58e-06	CbGpPWpGaD
Quinine—ABCB1—Metabolism—AKT1—hematologic cancer	4.45e-07	5.48e-06	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.34e-07	5.35e-06	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—AKT1—hematologic cancer	4.19e-07	5.16e-06	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—AKT1—hematologic cancer	4.15e-07	5.12e-06	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.55e-07	4.37e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.35e-07	4.13e-06	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.74e-07	3.38e-06	CbGpPWpGaD
